SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 424B7 - Prospectus [Rule 424(b)(7)]:
SEC Accession No. 0001601830-23-000073
Filing Date
2023-12-15
Accepted
2023-12-15 08:38:17
Documents
4

Document Format Files

Seq Description Document Type Size
1 424B7 rxrx-prospectussupplementt.htm 424B7 565659
2 EX-FILING FEES exhibit107-tempusfeetable.htm EX-FILING FEES 28244
3 image_0a.jpg GRAPHIC 13223
4 image_1a.jpg GRAPHIC 3981
  Complete submission text file 0001601830-23-000073.txt   618898
Mailing Address 41S RIO GRANDE STREET SALT LAKE CITY UT 84101
Business Address 41S RIO GRANDE STREET SALT LAKE CITY UT 84101 (385) 269-0203
RECURSION PHARMACEUTICALS, INC. (Filer) CIK: 0001601830 (see all company filings)

IRS No.: 464099738 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 424B7 | Act: 33 | File No.: 333-264845 | Film No.: 231488900
SIC: 2836 Biological Products, (No Diagnostic Substances)